Candel Therapeutics, Inc. (CADL)

Candel Therapeutics Statistics

Total Valuation

CADL has a market cap or net worth of $295.88 million. The enterprise value is $200.24 million.

Market Cap	295.88M
Enterprise Value	200.24M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025, before market open.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

CADL has 54.90 million shares outstanding. The number of shares has increased by 44.99% in one year.

Current Share Class	54.90M
Shares Outstanding	54.90M
Shares Change (YoY)	+44.99%
Shares Change (QoQ)	-5.98%
Owned by Insiders (%)	9.71%
Owned by Institutions (%)	45.16%
Float	45.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.37
P/TBV Ratio	3.24
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.04, with a Debt / Equity ratio of 0.09.

Current Ratio	7.04
Quick Ratio	6.84
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-24.93

Financial Efficiency

Return on equity (ROE) is -55.18% and return on invested capital (ROIC) is -41.28%.

Return on Equity (ROE)	-55.18%
Return on Assets (ROA)	-33.39%
Return on Invested Capital (ROIC)	-41.28%
Return on Capital Employed (ROCE)	-38.77%
Revenue Per Employee	n/a
Profits Per Employee	-$582,526
Employee Count	38
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.07% in the last 52 weeks. The beta is -0.89, so CADL's price volatility has been lower than the market average.

Beta (5Y)	-0.89
52-Week Price Change	-26.07%
50-Day Moving Average	5.76
200-Day Moving Average	6.47
Relative Strength Index (RSI)	50.09
Average Volume (20 Days)	818,483

Short Selling Information

The latest short interest is 7.43 million, so 13.54% of the outstanding shares have been sold short.

Short Interest	7.43M
Short Previous Month	7.27M
Short % of Shares Out	13.54%
Short % of Float	16.35%
Short Ratio (days to cover)	10.18

Income Statement

Revenue	n/a
Gross Profit	-20.04M
Operating Income	-35.38M
Pretax Income	-22.14M
Net Income	-22.14M
EBITDA	-34.41M
EBIT	-35.38M
Earnings Per Share (EPS)	-$0.52

Balance Sheet

The company has $100.69 million in cash and $8.34 million in debt, giving a net cash position of $92.35 million or $1.68 per share.

Cash & Cash Equivalents	100.69M
Total Debt	8.34M
Net Cash	92.35M
Net Cash Per Share	$1.68
Equity (Book Value)	90.21M
Book Value Per Share	1.64
Working Capital	88.89M

Cash Flow

In the last 12 months, operating cash flow was -$29.89 million and capital expenditures -$37,000, giving a free cash flow of -$29.93 million.

Operating Cash Flow	-29.89M
Capital Expenditures	-37,000
Free Cash Flow	-29.93M
FCF Per Share	-$0.55

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CADL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-44.99%
Shareholder Yield	-44.99%
Earnings Yield	-7.57%
FCF Yield	-10.23%

Analyst Forecast

The average price target for CADL is $20.33, which is 277.18% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.33
Price Target Difference	277.18%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2